BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 28, 2007
View Archived Issues
Diabetes snapshots: new data on GLP-1 receptor agonists
Read More
Strontium malonate offers better bioavailability than strontium ranelate
Read More
Oral fluoroquinolone prodrug safe in monkey studies
Read More
Studies reveal properties of potential COPD treatment aclidinium bromide
Read More
R-667 alters blood glucose in patients with COPD-emphysema
Read More
FDA accepts Nitec's IND for Lodotra
Read More
immatics begins phase II study of IMA-901 for renal cell cancer
Read More
Alkermes and Indevus state positive results from phase IIa study of ALKS-27 in COPD
Read More
Kyorin's novel fluoroquinolone more effective than moxifloxacin in vitro and in vivo
Read More
Kyowa Hakko launches Topina in Japan
Read More
VaxInnate commences clinical trials with M2e universal influenza vaccine
Read More
Santhera to file NDS for SNT-MC17 for Friedreich's ataxia in Canada
Read More
Recordati completes double-blind portion of phase III Urief trial for BPH
Read More
INCB-9471 safe and well tolerated in clinical studies
Read More
Wilex successfully completes WX-671 phase Ib trial in head and neck cancer
Read More
Alemtuzumab enters phase III program for MS indication
Read More
InterMune's ITMN-191 enters phase Ib trial in chronic HCV patients
Read More
Nastech initiates phase II clinical trial for insulin nasal spray
Read More
Protherics licenses CoVaccine HT adjuvant to Nobilon
Read More
NexMed files NDA for topically applied alprostadil cream
Read More
Velcura reports pre-IND meeting with FDA for VEL-0230 for bone disease
Read More
Knopp begins phase I trial of small-molecule KNS-760704 for ALS
Read More
Update on Pipex's development of oral Coprexa for Wilson's disease
Read More
SyntheMed's Repel-CV adhesion barrier recommended approval by FDA panel
Read More
Onyvax begins phase IIb trial of cell vaccine Onyvax-P for prostate cancer
Read More
FDA issues nonapprovable letter for Novartis' Prexige
Read More
MGI Pharma submits NDA to FDA for Aquavan
Read More
NeurogesX submits MAA to EMEA for NGX-4010 for peripheral neuropathic pain
Read More
Recent patents describe new treatment options for endocrine-related disorders
Read More